"On Friday, the US Food and Drug Administration released an environmental assessment report regarding a salmon-hybrid developed in the laboratories of AquaBounty. The FDA must wait two months before they make final their decision regarding the fate of the frankenfish, but through their study they have determined that the genetically engineered animal, the “AquAdvantage,” is safe enough to be sold.